Wed, March 4, 2020 - Wed, March 4, 2020 at B307 Clinical Center
Featuring Ping Wang presenting "Nucleic acid-based theranostics for type 1 diabetes treatment”
Learning Objectives:
• siRNA-based theranostics for transplanted islets;
• Development of endogenous pancreatic beta cell targeting nanodrugs for type 1 diabetes therapy;
• Manipulation of miRNA expression in hiPSC differentiated beta cells for type 1 diabetes treatment.